Colon Cancer Screening After 75

← Patient Education

Colon cancer screening after 75 is no longer a routine recommendation for everyone, and it is not automatically over either. The major United States guidelines treat ages 76 to 85 as a period for an individual decision, based on your health, your screening history, and what matters to you. This guide explains what the guidelines say about colon cancer screening after 75, who is most likely to benefit, what changes if you have had polyps, and how to prepare for the conversation with your physician.

This article is general education, not medical advice. It describes how the decision is usually approached. It cannot tell you whether you should be screened, and it does not apply to anyone with symptoms, which are discussed below.

What the guidelines say about colon cancer screening after 75

Three sets of recommendations shape how physicians in the United States approach colon cancer screening after 75. They use slightly different words and arrive at nearly the same place.

U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force recommendation, issued in May 2021 and still its current statement, recommends screening all adults aged 50 to 75 (grade A) and adults aged 45 to 49 (grade B). For adults aged 76 to 85 it gives a grade C recommendation: clinicians should selectively offer screening, because the evidence indicates that the net benefit of screening everyone in this age group is small. The Task Force says patients and clinicians should consider the person's overall health, prior screening history, and preferences.

The Task Force does not issue a graded recommendation for people older than 85. It states that in adults 86 or older, evidence on the benefits and harms of screening is lacking, and that other causes of death likely prevent any survival benefit that would outweigh the harms.

U.S. Multi-Society Task Force on Colorectal Cancer

The U.S. Multi-Society Task Force represents the three main gastroenterology societies: the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. Its 2022 update on the age to start and stop screening left its earlier position on stopping unchanged, because it found no new evidence to alter practice. For people aged 76 to 85, it says the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, colorectal cancer risk, and personal preference. It states that screening is not recommended after age 85.

American Cancer Society

The American Cancer Society guideline says people in good health with a life expectancy of more than 10 years should continue regular screening through age 75. For ages 76 through 85, the decision should be based on a person's preferences, life expectancy, overall health, and prior screening history. It says people over 85 should no longer get colorectal cancer screening.

What these recommendations have in common

None of the three names an age at which everyone should stop before 85, and none says everyone should continue. All three point to the same factors: how healthy you are, what screening you have already had, and what you prefer. In August 2026 the American Gastroenterological Association published a clinical practice update on older adults that repeats the point: the decision to continue colorectal cancer screening in people older than 75 should be individualized, based on an assessment of benefits, screening history, other medical conditions, and risks.

Why the answer changes with age

The risk of colorectal cancer and of advanced polyps rises with age, so it can seem strange that the guidance on colon cancer screening after 75 becomes more cautious, not less. The reason is timing.

The benefit of screening arrives years later

Screening works mainly by finding and removing precancerous polyps. The Multi-Society Task Force notes that there is a considerable lag between a precancerous polyp and a cancer that threatens life. A polyp removed today prevents a problem that might otherwise have appeared many years from now. The benefit of a screening test is collected in the future, while its risks are faced now. The longer a person can expect to live in good health, the more that trade favors screening. This is why life expectancy, not the date on a birth certificate, appears in every guideline.

The risks of colonoscopy rise with age

Serious complications from colonoscopy are uncommon at any age. In the evidence review behind the Preventive Services Task Force recommendation, screening colonoscopy was associated with about 14.6 major bleeding events and 3.1 perforations for every 10,000 procedures. When colonoscopy was done to follow up a positive stool test, the figures were about 17.5 serious bleeding events and 5.4 perforations per 10,000, presumably because more biopsies and polyp removals take place.

Those are averages across adult ages. The Task Force notes that limited evidence suggests harms such as perforation and bleeding increase with age. The Multi-Society Task Force adds that indirect harms, such as heart and lung events related to the procedure, are also more frequent in older adults, and it cites a study in which emergency visits and hospitalizations after colonoscopy were significantly more common in people older than 75 than in those aged 50 to 75. The bowel preparation and sedation can be harder on the body as well. Our guides to colonoscopy prep and colonoscopy sedation explain how each is planned around a person's health.

Prior screening lowers the remaining benefit

A person who has been screened regularly and had normal results has already collected much of the protection screening offers. The Preventive Services Task Force states that modeling studies estimate few additional life-years are gained when screening is extended past 75 among average-risk adults who were previously screened adequately.

Who is most likely to benefit from colon cancer screening after 75

The guidelines identify the people for whom colon cancer screening after 75 is more likely to be worthwhile.

• People who have never been screened. The Preventive Services Task Force states that adults who have never been screened are more likely to benefit, and the Multi-Society Task Force says people without prior screening may benefit the most in this age group.
• People in good overall health. Someone with few medical conditions and a long expected lifespan has more time to benefit and is better able to tolerate a colonoscopy and any treatment that follows.
• People who are overdue. A normal colonoscopy many years ago offers less reassurance than a recent one, and a stool test done once long ago is not the same as regular testing.

The Multi-Society Task Force describes a 2021 modeling study that shows how much health and history matter. It looked only at yearly stool testing and used Canadian cancer data, so it is an illustration and not a rule. In that model, women who had never been screened and had no other serious conditions benefited from screening until age 90, and unscreened men until age 88. In contrast, screening was not beneficial beyond age 66 for men or women with severe conditions such as congestive heart failure, chronic obstructive pulmonary disease, kidney failure, cirrhosis, or dementia. Two people of the same age can be in very different positions.

When stopping colon cancer screening after 75 is reasonable

Stopping colon cancer screening after 75 is not giving up, and it is not a sign that a person matters less. It reflects a judgment that a test is no longer likely to help and may cause harm. The guidelines support stopping, or not starting, in situations such as these:

• Age over 85. The Multi-Society Task Force and the American Cancer Society both say screening is not recommended beyond 85.
• Serious health conditions that limit life expectancy. The American Cancer Society ties continued screening to a life expectancy of more than 10 years.
• Up-to-date screening with normal results. For someone screened regularly through 75 with normal findings, the added benefit of further screening is small.
• A person who would not go through with follow-up. A stool test is only useful if a positive result leads to a colonoscopy. If a colonoscopy would not be safe or acceptable, that is worth discussing before any screening test is ordered.
• Personal preference. Every guideline lists the person's own preferences as part of the decision. Some people want every available test, and others would prefer to avoid procedures. Both are legitimate positions to bring to a physician.

Which tests are used for colon cancer screening after 75

The same tests are available after 75 as before: colonoscopy, yearly stool tests such as FIT, multitarget stool tests, and others. Our guide to colon cancer screening options compares them. The Multi-Society Task Force acknowledges that the choice among tests has been understudied in people over 75, so there is no guideline that names one test as preferred for this age group.

In practice the discussion often weighs a stool test, which carries no procedure risk on its own, against colonoscopy, which examines the whole colon and removes polyps in one visit but involves preparation and sedation. The point to settle first is what would happen after a positive stool test. The Preventive Services Task Force is clear that an abnormal stool test needs a follow-up colonoscopy, and that colonoscopy carries somewhat higher complication rates than a routine screening exam.

If you have had polyps: surveillance after 75

Screening means testing people with no history of polyps or cancer. A colonoscopy scheduled because polyps were removed in the past is called surveillance, and it follows a different set of recommendations. Our guide to colonoscopy results explains how the number, size, and type of polyps set the follow-up interval, and our overview of colon polyps and colorectal cancer covers how polyps relate to cancer risk.

The surveillance recommendations do not set an age at which follow-up ends. The Multi-Society Task Force's 2020 recommendations on follow-up after polyp removal state that more research is needed to determine whether the benefits of surveillance outweigh the immediate procedure risks for people older than 75 or those with multiple medical conditions. The 2026 American Gastroenterological Association update addresses the question directly and offers this advice:

• The decision to continue surveillance of colorectal polyps in people older than 75 should be individualized, based on an assessment of benefits, polyp history, other medical conditions, and risks.
• A formal look at a person's medical conditions, and the use of life expectancy tools, may help distinguish older adults most likely to benefit from those most likely to be harmed.
• With increasing age, colonoscopy is associated with a higher incidence of adverse events regardless of the reason it is done, so the reasoning behind the decision should be clearly documented for people older than 75.

In practical terms, a reminder that says you are due does not settle the matter after 75. A person in good health whose last exam found several or larger polyps is in a different position from someone whose last exam found one or two small ones. If you received a recall letter and are unsure whether another colonoscopy makes sense, that is a reasonable question to bring to a gastroenterologist, along with your prior reports.

Colon cancer screening after 75 for people at higher risk

The recommendations above apply to people at average risk. They are not written for people with a personal history of colorectal cancer, inflammatory bowel disease, a hereditary syndrome such as Lynch syndrome or familial adenomatous polyposis, or a strong family history. Those groups follow separate guidance, and the decision about when to stop is made individually with the treating physician. Our guides to family history and colon cancer screening and to Crohn's disease and ulcerative colitis cover those situations.

Symptoms are not screening, at any age

Everything above about colon cancer screening after 75 concerns people who feel well. The Preventive Services Task Force recommendation applies to adults who do not have signs or symptoms of colorectal cancer. A decision to stop screening is not a decision to ignore symptoms.

Blood in the stool, black stools, a lasting change in bowel habits, iron deficiency anemia, unexplained weight loss, or persistent abdominal pain should be evaluated at 78 or 88 just as at 58. The evaluation is tailored to the person, and it does not always mean a colonoscopy, but the symptom deserves attention. Our guide to when to see a gastroenterologist explains which symptoms are urgent.

How to prepare for a decision about colon cancer screening after 75

The guidelines call for shared decision-making about colon cancer screening after 75, which works well when both sides have the facts. It helps to bring:

• Your screening history. The dates and results of prior colonoscopies and stool tests, and the pathology reports if polyps were removed. If the records are elsewhere, the office can help request them.
• A current list of medical conditions and medications. Blood thinners, heart and lung conditions, kidney disease, and diabetes all affect how a colonoscopy is planned.
• Family history. Which relatives had colorectal cancer or polyps, and at what age.
• How your last procedure went. Any difficulty with the preparation or sedation, or with recovery afterward.
• Your own priorities. How you feel about the preparation, the procedure, and what you would want done if something were found.

Questions that often help: What did my last exam show, and how much protection does it still give me? Given my health, how likely am I to benefit from another test? What are the risks of a colonoscopy for someone with my conditions? Would a stool test be a reasonable alternative, and what happens if it is positive? If we stop now, what symptoms should bring me back?

A family member or caregiver is welcome in that conversation, and it can help to have a second person hear the reasoning. If cost is part of the decision, Medicare's coverage page states that Part B covers screening colonoscopy once every 120 months for people not at high risk and once every 24 months for those at high risk, and it does not list an upper age limit. Coverage and medical appropriateness are separate questions. Our guide to insurance coverage for a colonoscopy explains the details.

Colon cancer screening after 75 in Northern Virginia with GC of NoVA

Gastroenterology Center of Northern Virginia sees adults across Arlington, Annandale, and the surrounding communities for colorectal cancer screening, follow-up after polyps, and the evaluation of digestive symptoms. For patients older than 75, our physicians review prior colonoscopy and pathology reports, overall health, and medications, and talk through the benefits and risks of each option, including the option of not testing. The goal is a decision that fits the person, not a decision set by a calendar. We see patients at our Arlington office, next to VHC Health, and our Annandale office, in the Woodburn Medical complex.

If this is your first visit, our guide to your first gastroenterologist visit explains what to bring. To schedule a consultation about screening or surveillance, contact our Arlington office at (703) 522-7476 or our Annandale office at (703) 560-6106, or learn more at gcofnova.com.

This article is for general education and is not medical advice. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.